Last Updated: November 8, 2026

NULYTELY Drug Patent Profile

Name: NULYTELY Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Nulytely, and when can generic versions of Nulytely launch?

Nulytely is a drug marketed by Azurity and is included in one NDA.

The generic ingredient in NULYTELY is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for NULYTELY?
What are the global sales for NULYTELY?
What is Average Wholesale Price for NULYTELY?

Summary for NULYTELY

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	168
Clinical Trials:	9
Drug Prices:	Drug price information for NULYTELY
What excipients (inactive ingredients) are in NULYTELY?	NULYTELY excipients list
DailyMed Link:	NULYTELY at DailyMed

Drug patent expirations by year for NULYTELY

Recent Clinical Trials for NULYTELY

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Gastroenterology Services, Ltd.
ColonaryConcepts LLC	Phase 2
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran	Phase 3

See all NULYTELY clinical trials

US Patents and Regulatory Information for NULYTELY

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Azurity	NULYTELY	polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride	FOR SOLUTION;ORAL	019797-001	Apr 22, 1991	AA	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Azurity	NULYTELY-FLAVORED	polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride	FOR SOLUTION;ORAL	019797-002	Nov 18, 1994	AA	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.